Oncology Institute (TOIIW) Change in Receivables (2021 - 2026)

Oncology Institute (TOIIW) has reported Change in Receivables for 6 consecutive years, with -$864000.0 the latest figure, recorded in Q1 2026.

• Change in Receivables for Q1 2026 came in at -$864000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $11.4 million (up 85.84% YoY), and the FY2025 annual result was $12.3 million, up 105.99% from the prior year.
• Change in Receivables was -$864000.0 for Q1 2026 at Oncology Institute, down from -$641000.0 in the prior quarter.
• Over five years, Change in Receivables peaked at $21.0 million in Q4 2022 and troughed at -$6.2 million in Q4 2024.
• Average Change in Receivables over 5 years is $2.6 million, with a median of $59500.0 recorded in 2022.
• The widest YoY moves for Change in Receivables: up 4331.92% in 2022, down 540.11% in 2022.
• Over 5 years, Change in Receivables stood at $21.0 million in 2022, then tumbled by 119.52% to -$4.1 million in 2023, then slumped by 50.67% to -$6.2 million in 2024, then soared by 89.61% to -$641000.0 in 2025, then sank by 34.79% to -$864000.0 in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were -$864000.0 in Q1 2026, -$641000.0 in Q4 2025, and $12.7 million in Q3 2025.